Diagnostics News and Research

RSS

Metabolon raises additional $6 million in its Series C funding round

Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today that it has closed an additional $6 million in its Series C funding round. This brings the total funding raised in the company’s series C round to $12.3 million.

27 Oct 2009

Northwestern University to establish research center for the study of genes and their role in cancer

Northwestern University has been awarded a $13.6 million five-year grant from the National Cancer Institute (NCI) to establish an interdisciplinary research center for the study of genes and their role in cancer. A better understanding of the mechanisms could lead to better diagnostics and therapeutics and open up new directions for research.

27 Oct 2009

Hutchinson Center receives USAID grant to build a cancer clinic and medical-training facility in Africa

Building on the strengths of two institutions separated by nearly 9,000 miles over two continents - both renowned in their work in the fight against cancer - the United States Agency for International Development has awarded a $500,000 grant to Fred Hutchinson Cancer Research Center to aid in the construction of the first American cancer clinic and medical-training facility in Africa.

27 Oct 2009

Fred Hutchinson Cancer Research Center receives a $500,000 grant to construct cancer clinic in Africa

27 Oct 2009

eBioscience acquires privately held immunoassay technology pioneer Bender MedSystems

eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. The acquisition will provide eBioscience with over 1,000 high profile immunology and oncology products including the Instant ELISA® and FlowCytomix(TM) brands that target the life sciences and diagnostics markets.

27 Oct 2009

Syngenta Ventures makes equity investment in Metabolon

Syngenta Ventures announced today that it has made an equity investment in Metabolon, a privately-held U.S. biotechnology company focused on the use of metabolomics in research and diagnostics.

27 Oct 2009

National Cancer Institute awards Johns Hopkins $14.8 million for cancer research

Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.

26 Oct 2009

Thermo Fisher Scientific announces the availability of its Copeptin assay in Europe

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the availability in Europe of its new Copeptin assay, which helps medical personnel quickly and accurately diagnose acute myocardial infarction (AMI), commonly known as a heart attack.

From Thermo Fisher Scientific Inc. 26 Oct 2009

New nucleic acid test to screen donated blood for HIV-1 Group M RNA approved

Health Canada has approved a new nucleic acid test from Roche Diagnostics to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay.

From Roche Sequencing and Life Science 24 Oct 2009

Biomoda to complete Phase II clinical trial of Biomoda assay for lung cancer detection

Biomoda, Inc., a diagnostics company focused on the development of accurate, inexpensive and noninvasive in-vitro tests for the early detection of cancer, has met its recruitment goal for New Mexico veterans with a history of heavy smoking required to complete the Phase II clinical trial of Biomoda's early-stage diagnostic for lung cancer.

24 Oct 2009

Eurogentec to acquire Anaspec, a private proteomics company in California

Eurogentec S.A. (“Eurogentec”) announces today a final agreement for the acquisition of AnaSpec, Inc. (“AnaSpec” or the “Company”), a privately-held proteomics company based in Fremont, California.

24 Oct 2009

BD to acquire HandyLab

BD (Becton, Dickinson and Company)announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed.

From BD (Becton, Dickinson and Company) 24 Oct 2009

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed an agreement to acquire certain diagnostic businesses of Biotest AG for 45 million euros.

24 Oct 2009

Canada's first nationwide hearing healthcare structure launched

Lifestyle Hearing Corporation has officially launched Canada's first nationwide hearing healthcare structure called the Lifestyle Hearing Network. This initiative aims to provide Canadians coast to coast with a consistent source of premium medical clinics devoted to audiology.

23 Oct 2009

Dig Pink Volleyball Breast Cancer Awareness campaign to raise $1 million in support of breast cancer research

The Side-Out Foundation and its Dig Pink- Volleyball Breast Cancer Awareness campaign will launch a first of its kind clinical trial this month to examine the effects of individualized treatment on patients with metastatic breast cancer.

23 Oct 2009

Early diagnostic for ovarian cancer to be developed

BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.

23 Oct 2009

Also in global health news: Somali IDPS; MDR-TB elimination; Chagas; Zimbabwe disease, hunger

At the conclusion of a week-long visit to the region, Walter Kalin, a top U.N. human-rights official "says the international community is failing in its duty to internally displaced persons in Somalia. More than 1.5 million people in Somalia are believed to be IDPs," VOA News reports (Boswell, 10/21).

23 Oct 2009

ZyGEM and Phthisis Diagnostics to develop products for detecting infectious pathogens

ZyGEM Corp. Ltd. and Phthisis Diagnostics today announced that they have entered into an agreement to develop products enabling the detection of infectious pathogens in complex samples, such as stool, blood and water.

23 Oct 2009

NCI awards $2.8 million grant to Allegro Diagnostics

Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced that its clinical study for BronchoGen(TM), a diagnostic test for patients suspected of having lung cancer, will receive up to $2.8 million in funding for a Phase I/II Fast Track Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI).

22 Oct 2009

Metro Health Village implements Wyse Technology's healthcare IT solutions

Wyse Technology, the global leader in thin computing and client virtualization, today announced another successful customer implementation. Metro Health Village, located near Grand Rapids, Michigan, is one of the most comprehensive health care providers in west Michigan.

22 Oct 2009

Diagnostics News and Research

Metabolon raises additional $6 million in its Series C funding round

Northwestern University to establish research center for the study of genes and their role in cancer

Hutchinson Center receives USAID grant to build a cancer clinic and medical-training facility in Africa

Fred Hutchinson Cancer Research Center receives a $500,000 grant to construct cancer clinic in Africa

eBioscience acquires privately held immunoassay technology pioneer Bender MedSystems

Syngenta Ventures makes equity investment in Metabolon

National Cancer Institute awards Johns Hopkins $14.8 million for cancer research

Thermo Fisher Scientific announces the availability of its Copeptin assay in Europe

New nucleic acid test to screen donated blood for HIV-1 Group M RNA approved

Biomoda to complete Phase II clinical trial of Biomoda assay for lung cancer detection

Eurogentec to acquire Anaspec, a private proteomics company in California

BD to acquire HandyLab

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Canada's first nationwide hearing healthcare structure launched

Dig Pink Volleyball Breast Cancer Awareness campaign to raise $1 million in support of breast cancer research

Early diagnostic for ovarian cancer to be developed

Also in global health news: Somali IDPS; MDR-TB elimination; Chagas; Zimbabwe disease, hunger

ZyGEM and Phthisis Diagnostics to develop products for detecting infectious pathogens

NCI awards $2.8 million grant to Allegro Diagnostics

Metro Health Village implements Wyse Technology's healthcare IT solutions

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News